Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial

Engert, Andreas; Haverkamp, Heinz; Kobe, Carsten; Markova, Jana; Renner, Christoph; Ho, Antony; Zijlstra, Josee; Kral, Zdenek; Fuchs, Michael; Hallek, Michael; Kanz, Lothar; Doehner, Hartmut; Doerken, Bernd; Engel, Nicole; Topp, Max; Klutmann, Susanne; Amthauer, Holger; Bockisch, Andreas; Kluge, Regine; Kratochwil, Clemens; Schober, Otmar; Greil, Richard; Andreesen, Reinhard; Kneba, Michael; Pfreundschuh, Michael; Stein, Harald; Eich, Hans Theodor; Mueller, Rolf-Peter; Dietlein, Markus; Borchmann, Peter; Diehl, Volker

Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial

Autor(en):

Engert, Andreas; Haverkamp, Heinz; Kobe, Carsten; Markova, Jana; Renner, Christoph; Ho, Antony; Zijlstra, Josee; Kral, Zdenek; Fuchs, Michael; Hallek, Michael; Kanz, Lothar; Doehner, Hartmut; Doerken, Bernd; Engel, Nicole; Topp, Max; Klutmann, Susanne; Amthauer, Holger; Bockisch, Andreas; Kluge, Regine; Kratochwil, Clemens; Schober, Otmar; Greil, Richard; Andreesen, Reinhard; Kneba, Michael; Pfreundschuh, Michael; Stein, Harald; Eich, Hans Theodor; Mueller, Rolf-Peter; Dietlein, Markus; Borchmann, Peter; Diehl, Volker

Tübinger Autor(en):

Kanz, Lothar

Erschienen in:

Lancet (2012), Bd. 379, H. 9828, S. 1791-1799

Verlagsangabe:

Elsevier Science Inc

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1016/S0140-6736(11)61940-5

ISSN:

0140-6736